ST. PAUL, Minn., Jan. 23 /PRNewswire/ -- Cardiovascular Systems, Inc. (CSI) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock. Morgan Stanley & Co. Incorporated and Citigroup Global Markets Inc. are acting as joint book-running managers of the offering, with William Blair and Company L.L.C. acting as a co-manager of the offering. The number of shares to be offered and the price range for the offering have not been determined.
The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus relating to the offering may be obtained from Morgan Stanley & Co. Incorporated, Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, telephone: 1-866-718-1649 or via email at prospectus@morganstanley.com, or Citigroup Corporate and Investment Banking, Brooklyn Army Terminal, 140 58th Street, 8th Floor, Brooklyn, New York, NY 11220, telephone: 1-877-858-5407 or via email at batprospectusdept@citigroup.com.
A registration statement relating to the shares of CSI common stock has been filed with the Securities and Exchange Commission but has not yet become effective. The shares of CSI common stock may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the shares of CSI common stock in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
CSI is a medical device company focused on developing and commercializing interventional treatment systems for vascular disease.
CONTACT: Jim Flaherty of Cardiovascular Systems, Inc., +1-651-259-1611
Web site: http://www.cardiovascularsystemsinc.com/
